The fact that Cooper Strategy works with every stakeholder in the 340B ecosystem has left us well prepared to advise governmental entities how to overhaul their 340B program to minimize “gray areas” of the program and eliminate inequities.
It has been our experience that every stakeholder, including pharma manufacturers, realize the importance of the 340B program to the USA and their role in it. By working together with accurate data and transparency we can reach consensus with all stakeholders and produce more effective 340B programs.
